Pendal Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,096
| Closed | -$617K | – | 461 |
|
|
2022
Q1 | $617K | Buy |
+1,096
| New | +$617K | 0.01% | 383 |
|
|
2020
Q4 | – | Sell |
-526
| Closed | -$271K | – | 512 |
|
|
2020
Q3 | $271K | Sell |
526
-1,147
| -69% | -$591K | ﹤0.01% | 371 |
|
|
2020
Q2 | $755K | Buy |
1,673
+1,062
| +174% | +$479K | 0.01% | 268 |
|
|
2020
Q1 | $214K | Buy |
611
+372
| +156% | +$130K | ﹤0.01% | 333 |
|
|
2019
Q4 | $88.4K | Buy |
+239
| New | +$88.4K | ﹤0.01% | 398 |
|